ORKA-002
ORKA-002-212
Phase 2 small_molecule active
Quick answer
ORKA-002 for Plaque Psoriasis is a Phase 2 program (small_molecule) at Oruka Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oruka Therapeutics
- Indication
- Plaque Psoriasis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active